Showing results (51-60 of 92) with videos related to
Sort By:
Pageof 10
Proceedings of the National Academy of Sciences of the United States of America|May 10, 2001
Involvement of a human gene related to the Drosophila spen gene in the recurrent t(1;22) translocation of acute megakaryocytic leukemiaT Mercher, M B Coniat, R Monni, et al.British Journal of Cancer|December 6, 2000
Prognostic study of continuous variables (white blood cell count, peripheral blast cell count, haemoglobin level, platelet count and age) in childhood acute lymphoblastic leukaemia. Analysis Of a population of 1545 children treated by the French Acute Lymphoblastic Leukaemia Group (FRALLE)J Donadieu, M F Auclerc, A Baruchel, et al.Leukemia|December 13, 2005
Imatinib mesylate is effective in children with chronic myelogenous leukemia in late chronic and advanced phase and in relapse after stem cell transplantationF Millot, J Guilhot, B Nelken, et al.International Journal for Quality in Health Care : Journal of the International Society for Quality in Health Care|December 7, 2016
Use of proton pump inhibitors among older Australians: national quality improvement programmes have led to sustained practice changeNicole L Pratt, Lisa M Kalisch Ellett, Janet K Sluggett, et al.BMC Health Services Research|December 17, 2013
Bridging evidence-practice gaps: improving use of medicines in elderly Australian veteransElizabeth E Roughead, Lisa M Kalisch Ellett, Emmae N Ramsay, et al.Bone Marrow Transplantation|May 29, 2007
Long-term outcomes after allogeneic stem cell transplantation for children with hematological malignanciesC Ferry, G Gemayel, V Rocha, et al.British Journal of Haematology|August 29, 1998
Critical study of prognostic factors in childhood acute lymphoblastic leukaemia: differences in outcome are poorly explained by the most significant prognostic variables. Fralle group. French Acute Lymphoblastic Leukaemia study groupJ Donadieu, M F Auclerc, A Baruchel, et al.Bone Marrow Transplantation|February 1, 1996
Allogeneic bone marrow transplantation vs aggressive post-remission chemotherapy for children with acute myeloid leukemia in first complete remission. A prospective study from the French Society of Pediatric Hematology and Immunology (SHIP)G Michel, G Leverger, T Leblanc, et al.Leukemia|May 14, 2011
Expression of CD34 and CD7 on human T-cell acute lymphoblastic leukemia discriminates functionally heterogeneous cell populationsB Gerby, E Clappier, F Armstrong, et al.Leukemia|April 7, 2006
Incidence and prognostic impact of c-Kit, FLT3, and Ras gene mutations in core binding factor acute myeloid leukemia (CBF-AML)N Boissel, H Leroy, B Brethon, et al.Pageof 10